🛡️ Autoimmune Screen

What this panel can settle, and by what logic

Nine markers, and what they buy is a triage decision rather than a diagnosis: is there objective evidence of an inflammatory or autoimmune process, and which specialty should look at it.

1. ESR (Sed Rate) beside hs-CRP (High-Sensitivity C-Reactive Protein) is more informative than either alone. They rise through different mechanisms and on different clocks — CRP is a hepatic acute-phase protein that moves within hours, the sedimentation rate is a red-cell property that lags it by days and stays up for weeks. A high ESR with a flat CRP is the discordance worth noticing, and it points toward paraproteins, anemia or connective-tissue disease rather than toward acute infection.
2. ANA (Antinuclear Antibodies) with Rheumatoid Factor splits the referral, not the diagnosis. A positive ANA in someone with objective signs pushes toward the lupus-scleroderma-Sjogren family; a positive rheumatoid factor with inflammatory joint symptoms pushes toward inflammatory arthritis. Both are entry points to a specialist workup rather than conclusions Volkmann 2012.
3. Thyroid Antibodies (TPO + TgAb) is the highest-yield antibody on the list. Autoimmune thyroid disease is by far the commonest autoimmunity in the general population Klubo-Gwiezdzinska 2022, and antibody status predicts who will drift into hypothyroidism over the following years, which no single TSH can Razvi 2024.
4. The Complete Blood Count (CBC) with Differential and Comprehensive Metabolic Panel (CMP) are here as evidence, not as filler. An unexplained cytopenia, a raised creatinine or a low albumin alongside a positive ANA is what turns a common antibody into a finding worth chasing Zanussi 2023.

What it cannot settle, and what would

It cannot diagnose an autoimmune disease, and the ANA is the reason. Roughly 20% of the general population have a positive ANA Zanussi 2023 — a figure first established at population scale in a cross-sectional analysis of 4,754 NHANES participants Satoh 2012 — and when the diagnoses actually attached to a positive result are counted, most of them are not autoimmune disease Zanussi 2023. A positive result without symptoms or objective findings is far more likely to be a false alarm than a diagnosis Volkmann 2012. Buying this panel because you feel unwell and reading a positive ANA as the answer is the specific mistake this page exists to prevent.

It cannot exclude one either. Rheumatoid arthritis is seronegative in a substantial minority, axial spondyloarthritis and inflammatory bowel disease have no antibody here at all, and celiac disease needs tissue transglutaminase antibodies with a total IgA, which are not on this list. Nine normal results do not close the question.

It carries no confirmatory antibody. The tests that give a positive ANA meaning — double-stranded DNA, Smith, SSA and SSB, centromere, Scl-70 — are ordered after a positive screen and against a clinical picture, not bundled with it.

And it cannot see the joint or the organ. Synovitis on ultrasound, sacroiliitis on MRI, a salivary gland biopsy and a renal biopsy are what classify these diseases. Blood decides whether that imaging is warranted; it does not replace it.

Draw conditions that decide whether the money is wasted

Timing matters less here than on a hormone panel and more than the product page suggests.

1. Not within 2 to 3 weeks of an infection. This is the big one: infection raises ESR (Sed Rate), hs-CRP (High-Sensitivity C-Reactive Protein) and Ferritin together, and can transiently produce a positive ANA (Antinuclear Antibodies). A panel drawn in a bad week returns a picture that looks autoimmune and is not, and the follow-up cost of that is a specialist appointment.
2. Read Ferritin only against the CRP on the same tube. Ferritin is an acute-phase reactant, so inflammation inflates it and can hide iron deficiency behind a normal-looking number; the BRINDA method exists to make exactly that correction Luo 2023.
3. Season shifts the Vitamin D (25-Hydroxy) and the assay shifts it again. 25-hydroxyvitamin D carries real laboratory-to-laboratory variability Wise 2021, so a February result and an August result from two labs are not a trend.
4. Note biotin and any immunosuppressant on the form. High-dose biotin distorts immunoassay-based results, and a person already on prednisone or hydroxychloroquine will have a suppressed ESR and CRP that read as absence of disease.

How you would know it answered your question, and what each pattern means next

Five results, and what each one is actually worth.

• Positive ANA (Antinuclear Antibodies) at low titer, everything else normal, no symptoms: the commonest outcome and usually not a disease Satoh 2012. Do not repeat it — a titer does not become more meaningful by being measured twice Volkmann 2012.
• Positive ANA with a cytopenia on the Complete Blood Count (CBC) with Differential, a high ESR (Sed Rate), or renal changes on the Comprehensive Metabolic Panel (CMP): this is the combination that earns a rheumatology referral and extractable-nuclear-antigen testing Zanussi 2023.
• Positive Thyroid Antibodies (TPO + TgAb) with a normal TSH (Thyroid-Stimulating Hormone): not a disease today. Recheck TSH annually, because antibody positivity is what predicts the drift Razvi 2024, and thyroglobulin antibodies also interfere with thyroglobulin assays if that is ever measured Giovanella 2023.
• High ESR (Sed Rate) with a normal hs-CRP (High-Sensitivity C-Reactive Protein): repeat both in 4 weeks and, if it persists, ask for a serum protein electrophoresis rather than a broader autoantibody panel.
• Everything normal and symptoms continuing: this panel has excluded the common serologies. The productive next steps are structural — imaging of the symptomatic joint, or the Ferritin and Vitamin B12 route for fatigue Luo 2023.

Sources read for these sections

• Satoh M, et al. Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis and Rheumatism 2012 · PMID 22237992
• Zanussi JT, et al. Clinical diagnoses associated with a positive antinuclear antibody test in patients with and without autoimmune disease. BMC Rheumatology 2023 · PMID 37550754
• Volkmann ER, Taylor M, Ben-Artzi A. Using the antinuclear antibody test to diagnose rheumatic diseases: when does a positive test warrant further investigation?. Southern Medical Journal 2012 · PMID 22267099
• Klubo-Gwiezdzinska J, Wartofsky L. Hashimoto thyroiditis: an evidence-based guide to etiology, diagnosis and treatment. Polish Archives of Internal Medicine 2022 · PMID 35243857
• Razvi SS, et al. Changes in Thyroid Function and Autoimmunity in Older Individuals: Longitudinal Analysis of the Whickham Cohort. Journal of Clinical Endocrinology and Metabolism 2024 · PMID 39673773
• Luo H, et al. A Practical Guide to Adjust Micronutrient Biomarkers for Inflammation Using the BRINDA Method. Journal of Nutrition 2023 · PMID 36792034
• Giovanella L, et al. Thyroglobulin and thyroglobulin antibody: an updated clinical and laboratory expert consensus. European Journal of Endocrinology 2023 · PMID 37625447
• Wise SA, et al. Vitamin D Standardization Program (VDSP) intralaboratory study for the assessment of 25-hydroxyvitamin D assay variability and bias. Journal of Steroid Biochemistry and Molecular Biology 2021 · PMID 34010687